Weight Loss
Compounds supporting fat loss
Save 58%TR10
TZ10
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, engineered for its potent effects on glucose homeostasis and metabolic regulation.
Save 53%TR20
TZ20
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, engineered for its potent effects on glucose homeostasis and metabolic regulation.
Save 50%TR30
TZ30
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist, representing a significant advancement in metabolic research for its potent effects on glucose homeostasis and weight regulation.
Save 41%RT10
RT10
Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, demonstrating significant potential in metabolic research for obesity and type 2 diabetes.
Save 44%RT20
RT20
Retatrutide is an investigational triple-agonist peptide targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, showing significant promise in metabolic research.
Save 48%RT30
RT30
Retatrutide is a novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, showing significant promise in metabolic research, particularly for obesity and type 2 diabetes.
Save 24%TSM10
Tesamorelin 10mg
Tesamorelin is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH), primarily investigated for its role in stimulating endogenous growth hormone production. It is a potent research tool for studying metabolic regulation and body composition.
Save 40%MS40
Mots-c 40mg
Mots-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid mitochondrial-derived peptide (MDP) crucial for metabolic regulation, insulin sensitivity, and mitochondrial function, making it a key research tool for metabolic disorders.